Parasites, Hosts and Diseases

Skip to main navigation Skip to main content

OPEN ACCESS

Page Path

HOME
BROWSE ARTICLES

Author index detail contents
Liela Shirani-Bidabad	1 Article
Successful Treatment of Lupoid Cutaneous Leishmaniasis with Glucantime and Topical Trichloroacetic Acid (A Case Report) Mohamad Ali Nilforoushzadeh, Giti Sadeghian, Fariba Jaffary, Hengameh Ziaei, Liela Shirani-Bidabad, Parvin Mahzoni Korean J Parasitol 2008;46(3):175-177. Published online September 20, 2008 DOI: https://doi.org/10.3347/kjp.2008.46.3.175 Abstract PDF Lupoid leishmaniasis is a unique form of cutaneous leishmaniasis characterized by unusual clinical features and a chronic relapsing course, mostly caused by infection with Leishmania tropica. In this clinical form, 1-2 yr after healing of the acute lesion, new papules and nodules appear at the margin of the remaining scar. Herein, we describe a case of this clinical form that was resistant to 2 courses of treatments: systemic glucantime and then a combination therapy with allopurinol and systemic glucantime. However, marked improvement was seen after a combination therapy with topical trichloroacetic acid solution (50%) and systemic glucantime, and there were no signs of recurrence after 1 yr of follow-up. Citations Citations to this article as recorded by A History of the Advances in Chemical Peeling in Dermatologic Surgery Since 2000 Haya Raef, Harold J. Brody, Gary D. Monheit, William P. Coleman Dermatologic Surgery.2025; 51(9): 831. CrossRef Atypical Manifestations of Old World Cutaneous Leishmaniasis: A Systematic Review and Clinical Atlas of Unusual Clinical and Specific Anatomical Presentations Bahareh Abtahi‐Naeini, Seyed Naser Emadi, Zabihollah Shahmoradi, Mahsa Pourmahdi‐Boroujeni, Ali Saffaei, Fereshte Rastegarnasab Health Science Reports.2025;[Epub] CrossRef Old world cutaneous leishmaniasis in Iran: clinical variants and treatments Alireza Firooz, Hossein Mortazavi, Ali Khamesipour, Maryam Ghiasi, Robabeh Abedini, Kamran Balighi, Nafiseh Esmaili, Mansour Nassiri-Kashani, S. Ebrahim Eskandari, Mehdi Mohebali, Akram Mir Amin Mohammadi, Yahya Dowlati Journal of Dermatological Treatment.2021; 32(7): 673. CrossRef Novel Strategies and Pharmaceutical Agents for the Treatment of Leishmaniasis: A Review Mohammad A. Nilforoushzadeh, Maryam Heidari-Kharaji, Mehrak Zare, Elham Torkamaniha, Sima Rafati Anti-Infective Agents.2020; 18(2): 89. CrossRef Synergic Effect of Allopurinol in Combination with Nitroheterocyclic Compounds against Trypanosoma cruzi Ana Lia Mazzeti, Lívia de F. Diniz, Karolina R. Gonçalves, Ruan Schott WonDollinger, Tassiane Assíria, Isabela Ribeiro, Maria T. Bahia Antimicrobial Agents and Chemotherapy.2019;[Epub] CrossRef Comparison of Lesion Improvement in Lupoid Leishmaniasis Patients with Two Treatment Approaches Mahnaz Banihashemi, Mohamad Javad Yazdanpanah, Hossein Amirsolymani, Hadis Yousefzadeh Journal of Cutaneous Medicine and Surgery.2015; 19(1): 35. CrossRef Comparison Between Intralesional Meglumine Antimoniate and Combination of Trichloroacetic Acid 50% and Intralesional Meglumine Antimoniate in the Treatment of Acute Cutaneous Leishmaniasis: A Randomized Clinical Trial Mohammad Ali Nilforoushzadeh, Fariba Jaffary, Roya Derakhshan, Elaheh Haftbaradaran Journal of Skin and Stem Cell.2014;[Epub] CrossRef Lupoid leishmaniasis of the nose responding well to cryotherapy RYM BENMOUSLY MLIKA, HOUDA HAMMAMI, ASMA SIOUD, INçAF MOKHTAR, SAMY FENNICHE Dermatologic Therapy.2011; 24(3): 378. CrossRef Discoid chronic lupus erythematosus at the site of a previously healed cutaneous leishmaniasis: an example of isotopic response F. Bardazzi, F. Giacomini, F. Savoia, C. Misciali, A. Patrizi Dermatologic Therapy.2010; 23: S44. CrossRef 9,668 View 114 Download Crossref